HCM
ABBV icon

Harvey Capital Management’s AbbVie ABBV Stock Holding History

Harvey Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5,900
Closed -$429K – 75
2019
Q2 		$429K Buy
+5,900
New +$464K 0.21% 58
2015
Q3 		– Sell
-38,632
Closed -$2.63M – 83
2015
Q2 		$2.63M Buy
+38,632
New +$2.52M 0.89% 35

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Harvey Capital Management's ABBV Position: Q3 2019 in Review

Harvey Capital Management sold out of AbbVie (ABBV) in Q3 2019, closing a stake of 5,900 shares — an estimated $429K sold.

Harvey Capital Management first reported a position in ABBV in Q2 2015 and held it in 2 quarters. The position peaked at $2.63M in Q2 2015. 2,002 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

  • Harvey Capital Management reported no remaining AbbVie position as of Q3 2019 after selling out during the quarter.
  • Harvey Capital Management sold 5,900 AbbVie shares in Q3 2019, an estimated $429K.
  • Harvey Capital Management first reported a position in AbbVie in Q2 2015 and held it in 2 quarters.
  • Harvey Capital Management's AbbVie position peaked at $2.63M in Q2 2015.
  • 2,002 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on Harvey Capital Management's 13F filing for Q3 2019, filed 17 Oct 2019.